update on clinical trials for myeloproliferative neoplasms
Published 7 years ago • 215 plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
1:48
promising clinical trials for myeloproliferative neoplasms
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:27
insights into the reveal trial: the efficacy of ruxolitinib for the treatment of patients with pv
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:25
the current approach to managing patients with prefibrotic pmf
-
13:42
w hematologii jesteśmy w przełomowym momencie
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
59:35
january 27, 2024 img vmr with dr. maria mora pinzon - eras cv
-
1:16
considering enrolment in clinical trials for patients with amyloidosis
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:25
the recent approval of imetelstat in lr-mds based on results of the imerge trial
-
3:16
new mpn clinical trials & drugs in 2021
-
2:20
clinical trial updates in cml
-
0:42
upcoming trial updates in all
-
1:22
the uk impact transplant trials network: a national strategy to accelerate delivery of allosct rcts
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl